Procaps S.A

Procaps Group is a leading provider of Contract Development and Manufacturing services in softgel advanced technologies for the global pharmaceutical and nutraceutical industry. 

With 8 manufacturing facilities across North, Central & South America, Procaps Group’s CDMO businesses, Softigel, Sofgen Pharmaceuticals, Softcaps Brazil, and Funtrition, are bringing its extensive manufacturing capabilities and product development expertise in a wide array of Softge and gummy advanced technologies, helping companies to deliver health and innovation around the globe through new products and challenging projects in novel technologies. We are an integrated Softgel CDMO, offering end-to-end solutions from development across the delivery.

Our advanced delivery technologies, including Softgel advanced technologies, our proven formulation, manufacturing and regulatory expertise, has enabled us to become an integrated CDMO (iCDMO), giving customers full-service, turnkey solutions in prescription drugs, OTC and specialized nutraceuticals. Our differentiating strengths have enabled us to move into more difficult-to-produce compounds, formulations, dosage forms, and non-traditional manufacturing processes where few competitors can follow. Our Company is infused with a strong belief in the growing need for precisely the sort of generic drugs, specialty Pharma products, and advanced delivery technologies positioned in our pipeline, so developing long-term partnerships based on these breakthrough technologies is our state of mind.